Showing 5,761 - 5,780 results of 12,750 for search '"therapeutics"', query time: 0.10s Refine Results
  1. 5761

    Is narrow band imaging accurate to differentiate between high-risk and low-risk vocal fold leukoplakia? A systematic review and meta-analysis by Mina Sarabi Jamab, Arezoo Aghakouchakzadeh, Seied Omid Keyhan, Hosein Rafiemanesh, Ahmadreza Mirzaei, Mina Teimouri Badeleh Dareh

    Published 2024-09-01
    “…Vocal fold leukoplakia (VFL) is a pre-cancerous lesion that its management is still a therapeutic dilemma due to the need for timely diagnosis of its nature. …”
    Get full text
    Article
  2. 5762

    Leydig Cell Tumor Associated with Testicular Adrenal Rest Tumors in a Patient with Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency by Nadia Charfi, Mahdi Kamoun, Mouna Feki Mnif, Neila Mseddi, Fatma Mnif, Nozha Kallel, Basma Ben Naceur, Nabila Rekik, Hela Fourati, Emna Daoud, Zainab Mnif, Mourad Hadj Sliman, Tahia Sellami-Boudawara, Mohamed Abid

    Published 2012-01-01
    “…This distinction is interesting because LCTs and TARTs require different therapeutic approaches. Hereby, we present an unusual case of a 19-year-old patient with CAH due to 11β-hydroxylase deficiency, who presented with TARTs and an epididymal Leydig cell tumor.…”
    Get full text
    Article
  3. 5763

    Sirtuin 1 and Aging Theory for Chronic Obstructive Pulmonary Disease by V. Conti, G. Corbi, V. Manzo, G. Pelaia, A. Filippelli, A. Vatrella

    Published 2015-01-01
    “…Thus, there is an urgent need to clarify the molecular mechanisms responsible for this condition in order to identify new biomarkers and therapeutic targets. Processes including oxidant/antioxidant, protease/antiprotease, and proliferative/antiproliferative balance and control of inflammatory response become dysfunctional during aging as well as in COPD. …”
    Get full text
    Article
  4. 5764

    Rare Abdominal Wall Metastasis following Curative Resection of Gastric Cancer: What Can Be Learned from the Use of Percutaneous Catheters? by Arthur A. Parsee, Kerry L. Thomas, Masoumeh Ghayouri, Rutika Mehta, Kujtim Latifi, Jennifer Sweeney, Daniel Jeong, Abraham Ahmed

    Published 2020-01-01
    “…The oncologic patient provides many challenges and may require multiple catheters for drainage and at times infusion of nutrition or therapeutic agents. These foreign bodies should be scrutinized both clinically and radiographically, as they may create vulnerabilities in keeping malignant diseases contained and controlled. …”
    Get full text
    Article
  5. 5765

    From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments by Zhenlin Li, Zhenlin Li, Zhenlin Li, Zhenlin Li, Fangqi Lu, Fangqi Lu, Fangqi Lu, Fangqi Lu, Fujin Zhou, Fujin Zhou, Fujin Zhou, Dekun Song, Dekun Song, Dekun Song, Lunhui Chang, Lunhui Chang, Lunhui Chang, Lunhui Chang, Weiying Liu, Guorong Yan, Guorong Yan, Guorong Yan, Guolong Zhang, Guolong Zhang, Guolong Zhang, Guolong Zhang

    Published 2025-01-01
    “…It is of great significance to uncover the progression mechanisms from AK to cSCC, which will facilitate the early therapeutic intervention of AK before malignant transformation. …”
    Get full text
    Article
  6. 5766

    RETRACTED ARTICLE: Emerging insights into the role of IL-1 inhibitors and colchicine for inflammation control in type 2 diabetes by Jianbin Guan, Haimiti Abudouaini, Kaiyuan Lin, Kaitan Yang

    Published 2024-06-01
    “…This review provides a comprehensive examination of the inflammatory mechanisms underlying T2DM, focusing on the role of the NLRP3 inflammasome and interleukin-1β (IL-1β) in mediating inflammatory responses. We discuss the therapeutic potential of IL-1 inhibitors and colchicine, highlighting their mechanisms in inhibiting the NLRP3 inflammasome and reducing IL-1β production. …”
    Get full text
    Article
  7. 5767

    Circulating T Cell Subsets in Type 1 Diabetes by Aldo Ferreira-Hermosillo, Paola Santana-Sánchez, Ricardo Vaquero-García, Manuel R. García-Sáenz, Angélica Castro-Ríos, Adriana K. Chávez-Rueda, Rita A. Gómez-Díaz, Luis Chávez-Sánchez, María V. Legorreta-Haquet

    Published 2025-01-01
    “…By employing flow cytometry to compare the characteristics of T cells, we can pinpoint potential indicators of treatment response or therapeutic inefficacy. Our study reveals elevated prolactin (PRL) levels in T1D patients, along with a decreased production of key cytokines. …”
    Get full text
    Article
  8. 5768

    Elevated CA-125 as Humoral Biomarker of Congestive Heart Failure: Illustrative Cases and a Short Review of Literature by Attila Frigy, Boglárka Belényi, Ádám Kirchmaier, Nándor Fekete, István Adorján Szabó

    Published 2020-01-01
    “…Humoral biomarkers in HF are capable to reflect different aspects of the cardiac morpho-functional changes and the related pathophysiological processes and could have important diagnostic, prognostic, and therapeutical roles. CA-125 is a well-known tumor marker (mainly for ovarian cancer), and also a useful, but less applied cardiac biomarker. …”
    Get full text
    Article
  9. 5769

    Mathematical modeling and treating tumors in a fuzzy environment by Aadil Sheergojri, Pervaiz Iqbal

    Published 2024-03-01
    “…This article begins with an overview of mathematical models for tumor development and treatment, which consider stochastic perturbations a therapeutic remedy. Also, it has been demonstrated that fuzzy modeling approaches may be used to investigate the impacts of various components on tumor development estimation, minimize tumor uncertainty, and attain a degree of realism.…”
    Get full text
    Article
  10. 5770

    Iron Chelation Therapy in Myelodysplastic Syndromes by Emanuela Messa, Daniela Cilloni, Giuseppe Saglio

    Published 2010-01-01
    “…Iron chelation therapy may be a therapeutic option for these patients, especially since the approval of oral iron chelators, which are easier to use and better accepted by the patients. …”
    Get full text
    Article
  11. 5771

    2-Cys Peroxiredoxins: Emerging Hubs Determining Redox Dependency of Mammalian Signaling Networks by Jinah Park, Sunmi Lee, Sanghyuk Lee, Sang Won Kang

    Published 2014-01-01
    “…These discoveries help reveal the redox signaling landscape in mammalian cells and may further provide a new paradigm of therapeutic approaches based on redox signaling.…”
    Get full text
    Article
  12. 5772

    Chylous Ascites: A Rare Adverse Effect of Methimazole Treatment for Grave’s Disease—A Case Report and Review of the Literature by Tawfik Khoury, Ronen Schneider

    Published 2015-01-01
    “…The patient later underwent therapeutic thyroidectomy, after which all features of thyrotoxicosis had improved.…”
    Get full text
    Article
  13. 5773

    L’intervention féministe sous l’influence de l’intersectionnalité : enjeux organisationnels et communicationnels au sein des organismes féministes au Québec by Isabelle Marchand, Christine Corbeil, Carole Boulebsol

    Published 2020-12-01
    “…In Quebec, feminist intervention was spread significantly in the mid-1970s and presented itself as a therapeutic and political alternative to traditional therapies in the field of mental health and the fight against gender-based violence, to support women and defend their rights. …”
    Get full text
    Article
  14. 5774

    Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research by Cheol-Kyu Park, MD, PhD, Maryam Khalil, BSc, Nhu-An Pham, PhD, Stephanie Wong, BSc, Dalam Ly, PhD, Adrian Sacher, MD, FRCPC, Ming-Sound Tsao, MD, FRCPC

    Published 2025-03-01
    “…We highlight the various approaches to generate them, factors that are critical to successfully establishing such models, their respective limitations, and considerations in model selection for preclinical lung cancer immuno-oncology research and therapeutic studies.…”
    Get full text
    Article
  15. 5775

    Biomarkers for Hepatocellular Carcinoma by Tara Behne, M. Sitki Copur

    Published 2012-01-01
    “…These markers not only help in prediction of prognosis or recurrence but may also assist in deciding appropriate modality of therapy and may represent novel potential targets for therapeutic interventions. In this paper, a summary of most relevant available data from published papers reporting various tissue and serum biomarkers involved in hepatocellular carcinoma was presented.…”
    Get full text
    Article
  16. 5776

    The Role of Exosomes in Cancer Progression and Therapy by Shynggys Sergazy, Roza Seydahmetova, Alexandr Gulyayev, Zarina Shulgau, Mohamad Aljofan

    Published 2025-01-01
    “…Recent advances have shown the potential for exosomes to be used in early disease detection and in targeted drug therapy by delivering therapeutic agents specifically to tumor sites. Despite the promising applications, a number of challenges remain, including exosome isolation and characterization, as well as their inherent heterogeneity. …”
    Get full text
    Article
  17. 5777

    Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis by D. V. Garbuzenko

    Published 2022-01-01
    “…In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver fibrosis-specific drug therapy and treatment for metabolic syndrome-related diseases. …”
    Get full text
    Article
  18. 5778

    Advancing allergy practice in India for respiratory physician by Shambo S. Samajdar, Saibal Moitra

    Published 2024-06-01
    “…The landscape of allergy practice in India is undergoing transformative changes, shifting from traditional symptom management to embracing advanced diagnostic and therapeutic modalities for disease modification. This evolution is propelled by the integration of subcutaneous immunotherapy, biologic treatments, and the exploration of probiotics, alongside advancements in diagnostic approaches such as component-resolved diagnostics (CRD) and basophil activation tests. …”
    Get full text
    Article
  19. 5779

    GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites by Zhihua Sun, Peiyi Li, Xiao Wang, Shuchang Lai, Hong Qiu, Zhi Chen, Shidi Hu, Jie Yao, Jie Shen

    Published 2020-01-01
    “…Although glucagon-like peptide 1 receptor agonists (GLP-IRAs) show therapeutic effects for PCOS, its target and underlying mechanism remains elusive. …”
    Get full text
    Article
  20. 5780

    In Vivo Molecular Imaging in Retinal Disease by Fang Xie, Wenting Luo, Zhongyu Zhang, Dawei Sun

    Published 2012-01-01
    “…In vivo molecular imaging has a great potential to impact medicine by detecting diseases or screening disease in early stages, identifying extent of disease, selecting disease and patient-specific therapeutic treatment, applying a directed or targeted therapy, and measuring molecular-specific effects of treatment. …”
    Get full text
    Article